| ID | Name | CAS | Data |
Tfus (K) |
| 49-566-0 |
Androst-2,4-dien-3,17«beta»-diol, (3,17-O)-diTBDMSi
|
|
4 | 387.94 |
| 49-725-3 |
N-isobutyl-2-(trimethylsilyloxy]-4,5-dihydro-1H-imidazole-1-carboxamide
|
|
4 | 310.95 |
| 50-501-9 |
5«beta»-Androstan-17-one, 3«alpha»,11«beta»-bis(trimethylsiloxy)-
|
17562-89-9 |
4 | 379.74 |
| 50-917-8 |
Silane, [[(17«beta»)-2-methoxyestra-1,3,5(10)-triene-3,17-diyl]bis(oxy)]bis[trimethyl-
|
29825-47-6 |
4 | 384.80 |
| 51-409-1 |
17-Epimetandienone (Androst-1,4-dien-17B-methyl-17A-ol-3-one), TMS
|
|
4 | 399.71 |
| 51-755-7 |
17«alpha»,20«beta»,21-Trihydroxypregn-4-en-3-one, methylboronate
|
|
4 | 429.55 |
| 52-766-4 |
5«beta»-Cholane-3«alpha»,7«alpha»,24-triol, TMS
|
|
4 | 365.74 |
| 53-503-4 |
Methyl 17A-hydroxy-3-oxoandrost-4-ene-17B-carboxylate, 3-MO
|
|
4 | 439.96 |
| 53-570-0 |
17.alpha.,21-Dihydroxypregn-4-en-3,20-dione, 17,21-dimethylsilylene
|
|
4 | 418.18 |
| 53-652-9 |
17-«alpha»-Hydroxy-17-«beta»-methyl-5-«beta»-androstan-3-one, 17-TMS
|
|
4 | 402.79 |
| 54-943-5 |
O-methyl,o-(2,4,5,-trichlorophenyl)-tert-butyl phosphoramidothioate
|
16805-76-8 |
4 | 359.23 |
| 56-004-5 |
17«alpha»,20«beta»,21-Trihydroxypregn-4-en-3-one, bis-TMS
|
|
4 | 401.21 |
| 56-144-0 |
3«alpha»-hydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
4 | 359.47 |
| 56-164-8 |
5«beta»-Androst-1-ene-3,17-dione, mono-TMS
|
|
4 | 382.99 |
| 57-666-0 |
Androst-4-en-3-one, 17-[(trimethylsilyl)oxy]-, (17«alpha»)-
|
16134-45-5 |
4 | 375.75 |
| 59-197-9 |
2,7-Dimethylbenzo-[1,2-d,5,4-d]bisoxazole
|
|
4 | 477.63 |
| 59-880-0 |
Methyltestosterone (Androst-4-en-17A-methyl-17B-ol-3-one), TMS
|
|
4 | 382.73 |
| 60-846-6 |
9H-purine, 6-chloro-9-(2',3'-o-isopropylidene-beta-d-ribofuranosyl)-
|
39824-26-5 |
4 | 414.28 |
| 60-850-1 |
Phosphorothioic acid, O,O-diethyl O-(p-methylsulfonyl)phenyl ester
|
14255-72-2 |
4 | 329.24 |
| 62-409-9 |
N-tert-Butyl-N'-trimethylsilyl-6-methoxy-1,3,5-triazine-2,4-diamine
|
|
4 | 393.33 |
| 62-475-6 |
3-«beta»,17-«beta»-Dihydroxy-5-androsten-16-one, TMS
|
|
4 | 401.16 |
| 62-513-3 |
R,S-3',4'-methylenedioxy-«alpha»-pyrrolidinopropiophenone-M (desmethylene-methyl-), TMS
|
|
4 | 369.09 |
| 62-557-5 |
Phosphoramidothioic acid, o-ethyl-o-(2,4,5-trichlorophenyl) ester
|
2775-95-3 |
4 | 357.29 |
| 62-839-2 |
(4,6-Dichloro-[1,3,5]triazin-2-yl)-(1,1,3,3-tetramethyl-butyl)-amine
|
|
4 | 427.82 |
| 63-477-3 |
5-«alpha»-Pregnane-17-«alpha»,20-«beta»,21-triol, tris-TMS
|
|
4 | 354.02 |
| 63-483-6 |
1,1,1-tris(Hydroxymethyl)propane, bis(tert-butyldimethylsilyl) ether
|
|
4 | 346.44 |
| 64-045-1 |
1-(4-Chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol, trimethylsilyl- ether
|
|
4 | 319.11 |
| 64-108-1 |
5-Chloro-N-(2-chloro-4-nitro-phenyl)-N-trimethylsilyl-2-trimethylsilyloxybenzamide
|
|
4 | 365.24 |
| 64-392-6 |
[1,3,5]Triazine-2,4-diamine, 6-chloro-N,N'-dicycloheptyl-
|
|
4 | 446.64 |
| 64-755-3 |
N2-Cyclopropyl-1,3,5-triazine-2,4,6-triamine N4,N6-diacetyl
|
|
4 | 475.26 |
| 64-949-8 |
5-«alpha»-Pregnane-3-«beta»,17-«alpha»,20-«beta»-triol, methylboronate
|
|
4 | 433.38 |
| 65-196-3 |
Cinnamic acid, 4-methoxy-3-(tert-butyldimethylsilyl)oxy-, tert-butyldimethylsilyl ester
|
|
4 | 381.96 |
| 65-250-2 |
3«alpha»,16«beta»-Dihydroxy-5-androsten-17-one, di-TMS
|
|
4 | 393.09 |
| 65-893-9 |
Androstane-11,17-dione, 3-[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»)-
|
5042-90-0 |
4 | 412.86 |
| 66-380-7 |
5-«alpha»-Pregnane-17-«alpha»,20-«beta»,21-triol, methylboronate
|
|
4 | 420.73 |
| 66-828-0 |
O-methyl,o-(2,4,5-trichlorophenyl)n-ethyl phosphoramidothioate
|
|
4 | 333.76 |
| 66-881-1 |
Ethanimidothioic acid, 2-(dimethylamino)-N-hydroxy-2-oxo-, methyl ester
|
30558-43-1 |
4 | 355.15 |
| 67-060-1 |
4-Androsten-17«beta»-ol-3-one (testosterone), MO-TMS
|
|
4 | 368.05 |
| 67-507-5 |
3«alpha»,7«beta»-dihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
4 | 357.46 |
| 67-626-3 |
Androstan-17-one, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (3«alpha»,5«alpha»)-
|
57711-45-2 |
4 | 405.34 |
| 67-973-8 |
2,3,16,17-Tetrakis[(trimethylsilyl)oxy]estra-1,3,5(10)-triene, (16«alpha»,17«beta»)-
|
51497-46-2 |
4 | 368.87 |
| 68-176-2 |
2H-1-Benzopyran-2-one, 7-methoxy-8-(3-methylbutyl)-
|
|
4 | 349.85 |
| 69-642-3 |
3«alpha»,6«alpha»-Dihydroxy-5«beta»-cholanic acid, methyl ester, TMS
|
|
4 | 379.34 |
| 70-181-3 |
Bis-(4-(2,5-dioxo-2,5-dihydropyrrol-1-yl)-phenyl)-ether
|
|
4 | 468.70 |
| 70-211-9 |
3«alpha»-Hydroxy-5«beta»-pregnan-20-one, O-trimethylsilyl
|
18880-83-6 |
4 | 394.12 |
| 70-904-0 |
Phosphorothioic acid, O-[5-chloro-1-(1-methylethyl)-1H-1,2,4-triazol-3-yl] O,O-diethyl ester
|
42509-80-8 |
4 | 313.47 |
| 71-157-9 |
Silane, [[(3«beta»,17«beta»)-17-methylandrost-5-ene-3,17-diyl]bis(oxy)]bis[trimethyl-
|
39780-59-1 |
4 | 378.23 |
| 71-481-9 |
17«beta»-Hydroxy-5«alpha»-androstan-3-one, trimethylsilyl ether
|
18899-43-9 |
4 | 387.41 |
| 71-643-9 |
Pregn-5-en-20-one, 3«beta»-(trimethylsiloxy)-, O-methyloxime
|
25830-38-0 |
4 | 381.05 |
| 72-834-6 |
1,3,5(10)-Oestratriene-3,17.beta.-diol, 3-TBDMS-17-HFB
|
|
4 | 386.28 |
| 75-216-9 |
4H-1-BENZOPYRANE-4-ONE, 2-(3,4-DIHYDROXYPHENYL)-5,7-DIHYDROXY-
|
|
4 | [601.00; 610.58] |
| 75-229-5 |
1H-1,2,4-Triazole-1-ethanol, «beta»-((2,4-dichlorophenyl)methyl)-«alpha»-(1,1-dimethylethyl)-,(R*,R*)-(.+/-.)-
|
75736-33-3 |
4 | 411.34 |
| 77-092-5 |
2H-1-Benzopyran-2-one, 7,8-dihydroxy-6-methoxy-
|
574-84-5 |
4 | 473.25 |
| 78-327-3 |
2H-1-Benzopyran-2-one, 3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxy-
|
|
4 | 424.72 |
| 79-609-9 |
9H-purine-6-thiol, 2-fluoro-9-beta-d-ribofuranosyl-
|
792-16-5 |
4 | 499.32 |
| 80-149-8 |
Androst-5-en-17-one, 3,16-bis[(trimethylsilyl)oxy]-, (3«beta»,16«beta»)-
|
40822-67-1 |
4 | 393.09 |
| 80-894-1 |
4,6-Dichloro-1-phenol-2-sulfonic acid, sodium salt
|
|
4 | 613.02 |
| 82-199-1 |
4H-1-Benzopyran-4-one, 5-hydroxy-7-methoxy-2-phenyl-
|
520-28-5 |
4 | 466.19 |
| 82-200-8 |
4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-
|
1447-88-7 |
4 | 529.29 |
| 82-223-3 |
Formamide, n-(10,11-dihydro-5h-dibenzo(a,d)-cyclohepten-5-yl)-
|
62371-00-0 |
4 | 422.04 |
| 82-858-9 |
4H-1-Benzopyran-4-one, 5-hydroxy-2-(4-hydroxyphenyl)-6,7-dimethoxy-
|
6601-62-3 |
4 | 501.32 |
| 83-349-3 |
Dimethyl{bis[(3-methylbut-3-en-1-yl)oxy]}silane
|
|
4 | 211.95 |
| 84-447-3 |
Pregn-4-en-3-one, 20,21-[(methyleneborylene)bis(oxy)]-, (20R)-
|
|
4 | 407.55 |
| 84-981-0 |
2H-1-Benzopyran-2-one, 7-methoxy-6-(3-methyl-2-butenyl)-
|
581-31-7 |
4 | 363.58 |
| 84-985-6 |
Acetic acid, [(3,4-dimethyl-2-oxo-2h-1-benzopyran-7-yl)oxy]-, ethyl ester
|
35679-90-4 |
4 | 373.38 |
| 85-471-5 |
Urea, 1,1'-p-phenylenebis[3-(2-chloroethyl)-3-nitroso-
|
|
4 | 437.80 |
| 86-261-7 |
1-Aminocyclopentanecarboxylic acid, N-(but-3-en-1-yloxycarbonyl)-, hexadecyl ester
|
|
4 | 335.32 |
| 86-528-1 |
1-Aminocyclopentanecarboxylic acid, N-(but-3-en-1-yloxycarbonyl)-, pentadecyl ester
|
|
4 | 333.38 |
| 86-622-6 |
Pregn-5-en-20-one, 3-[(dimethyl-2-propenylsilyl)oxy]-, (3«beta»)-
|
61727-39-7 |
4 | 373.94 |
| 89-596-3 |
4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-methoxyphenyl)-
|
485-72-3 |
4 | 497.33 |
| 90-197-4 |
4H-1-Benzopyran-4-one, 5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-
|
5128-44-9 |
4 | 479.84 |
| 91-046-0 |
9H-purine, 6-amino-2-(methylamino)-9-beta-d-ribofuranosyl-
|
13364-95-9 |
4 | 519.64 |
| 91-275-6 |
Urea, 1-(2-chloroethyl)-3-[p-(dimethylcarbamoyl)phenyl]-1-nitroso-
|
|
4 | 404.65 |
| 92-271-9 |
Acetic acid, (3-ethyl-4-methyl-7-coumarinyloxy)-, ethyl ester
|
|
4 | 362.25 |
| 94-011-5 |
Urea, 1,1'-p-phenylenebis[3-(2-hydroxyethyl)-3-nitroso-
|
116401-09-3 |
4 | 441.12 |
| 94-340-0 |
Urea], 1,1'-p-phenylene-bis[3-methyl-3-nitroso-
|
94602-15-0 |
4 | 477.88 |
| 94-666-9 |
1-Aminocyclopentanecarboxylic acid, N-(but-3-en-1-yloxycarbonyl)-, decyl ester
|
|
4 | 322.42 |
| 95-419-2 |
1-Aminocyclopentanecarboxylic acid, N-(but-3-en-1-yloxycarbonyl)-, tetradecyl ester
|
|
4 | 331.32 |
| 95-653-2 |
1-Aminocyclopentanecarboxylic acid, N-(but-3-en-1-yloxycarbonyl)-, tridecyl ester
|
|
4 | 329.22 |
| 95-942-1 |
Pregn-4-ene-3,20-dione, 17,21-[(methylborylene)bis(oxy)]-
|
|
4 | 429.16 |
| 96-096-0 |
2-Aminopent-4-enoic acid, N-(but-2-yn-1-yloxycarbonyl)-, dodecyl ester
|
|
4 | 327.59 |
| 96-120-2 |
1-Aminocyclopentanecarboxylic acid, N-(but-3-en-1-yloxycarbonyl)-, undecyl ester
|
|
4 | 324.67 |
| 96-553-2 |
1-Aminocyclopentanecarboxylic acid, N-(but-3-en-1-yloxycarbonyl)-, nonyl ester
|
|
4 | 319.94 |
| 96-578-5 |
3-«alpha»-Hydroxy-12-keto-5-«beta»-cholanoic acid, MeTMS
|
|
4 | 402.22 |
| 97-630-5 |
2-Aminopent-4-enoic acid, N-(but-2-yn-1-yloxycarbonyl)-, octyl ester
|
|
4 | 313.51 |
| 97-662-0 |
1-Aminocyclopentanecarboxylic acid, N-(but-3-en-1-yloxycarbonyl)-, octyl ester
|
|
4 | 316.93 |
| 98-236-2 |
12«alpha»-Hydroxy-5«alpha»-cholanic acid, methyl ester, TMS
|
|
4 | 358.55 |
| 99-074-1 |
1-Aminocyclopentanecarboxylic acid, N-(but-3-en-1-yloxycarbonyl)-, dodecyl ester
|
|
4 | 327.09 |
| 99-211-8 |
2-Aminopent-4-enoic acid, N-(but-2-yn-1-yloxycarbonyl)-, tridecyl ester
|
|
4 | 330.41 |
| 99-253-2 |
Imidazole-4(or 5)-carboxamide, n-benzyl-5(or 4)-(benzylamino)-
|
116373-95-6 |
4 | 498.49 |
| 99-392-8 |
1-Aminocyclopentanecarboxylic acid, N-(but-3-en-1-yloxycarbonyl)-, heptyl ester
|
|
4 | 313.79 |
| 100-376-3 |
2-[4-(4-chlorophenyl)-2-phenyl-1,3-thiazol-5-yl]acetic acid
|
|
4 | 434.65 |
| 101-344-7 |
5-hydroxy-7,7-dioxo-5,6-dihydro-4H-thieno[5,4-b]thiopyran-2-sulfonamide
|
|
4 | 467.10 |
| 101-345-6 |
7-hydroxy-6,7-dihydro-5H-thieno[4,5-b]thiopyran-2-sulfonamide
|
|
4 | 430.65 |
| 101-346-5 |
7-oxo-5,6-dihydrothieno[4,5-b]thiopyran-2-sulfonamide
|
|
4 | 486.65 |
| 101-348-3 |
7,7-dioxo-5,6-dihydro-4H-thieno[5,4-b]thiopyran-2-sulfonamide
|
|
4 | 458.70 |
| 101-349-2 |
4,4,7-trioxo-5,6-dihydrothieno[4,5-b]thiopyran-2-sulfonamide
|
|
4 | 517.92 |
| 101-350-0 |
7-hydroxy-4,4-dioxo-6,7-dihydro-5H-thieno[4,5-b]thiopyran-2-sulfonamide
|
|
4 | 473.22 |
| 101-446-4 |
2-[5-methoxy-2-methyl-1-(3-phenylprop-2-enoyl)indol-3-yl]acetic acid
|
|
4 | 446.92 |
| 102-396-9 |
4-amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
|
|
4 | 490.65 |
|
« Previous Results
Next Results »
|